2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow setrobuvir: new trials by email Literature Review of setrobuvir trials Research Report on setrobuvir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Setrobuvir in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Genotype 1 Chronic Hepatitis C peginterferon alfa-2a [Pegasys], placebo, ribavirin [Copegus] - Hepatitis C, Chronic | Phase 2 | Completed | Hoffmann-La Roche | 283 | 2011-01-01 | 2016-11-02 |
| Safety, Tolerability, and Antiviral Activity of ANA598 Administered in Combination With Pegylated Interferon and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection placebo, ANA598, Peginterferon - HCV Infection | Phase 2 | Completed | Hoffmann-La Roche | 97 | 2009-09-01 | 2017-03-31 |
Hepatitis C (1) · Hepatitis C, Chronic (1)
Puerto Rico (1) · United States (1)